Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020838

Expand all

ATACAND (CANDESARTAN CILEXETIL)
4MG
Marketing Status: Prescription

Active Ingredient: CANDESARTAN CILEXETIL
Proprietary Name: ATACAND
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020838
Product Number: 001
Approval Date: Jun 4, 1998
Applicant Holder Full Name: ANI PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ATACAND (CANDESARTAN CILEXETIL)
8MG
Marketing Status: Prescription

Active Ingredient: CANDESARTAN CILEXETIL
Proprietary Name: ATACAND
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 8MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020838
Product Number: 002
Approval Date: Jun 4, 1998
Applicant Holder Full Name: ANI PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ATACAND (CANDESARTAN CILEXETIL)
16MG
Marketing Status: Prescription

Active Ingredient: CANDESARTAN CILEXETIL
Proprietary Name: ATACAND
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 16MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020838
Product Number: 003
Approval Date: Jun 4, 1998
Applicant Holder Full Name: ANI PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

ATACAND (CANDESARTAN CILEXETIL)
32MG
Marketing Status: Prescription

Active Ingredient: CANDESARTAN CILEXETIL
Proprietary Name: ATACAND
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 32MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020838
Product Number: 004
Approval Date: Jun 4, 1998
Applicant Holder Full Name: ANI PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information